Comments
A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients.
The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow).
The medicine was launched here yesterday at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute, Lucknow and D N Mani Senior Scientist CSIR—Central Institute for Medicinal And Aromatic Plants, Lucknow.
It would help maintain normal Blood Glucose Metabolism and also reduce chances of long term complications, they said.
AIMIL Pharmaceuticals, a private company, has been given the marketing right of the Ayurvedic proprietary medicine, a company release said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.